Stay updated on Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study's history now includes a new revision entry labeled v3.6.4, and the previous revision v3.6.3 is removed from the log. This reflects an update to the record's revision history rather than changes to study data.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry, v3.6.3, was added to the record history, replacing the previous v3.6.2. This reflects a site-level update to the page rather than changes to the study data.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry (v3.6.2) was added to the record history and the older revision (v3.6.0) was removed, updating the study record's version history.SummaryDifference0.1%

- Check54 days agoChange DetectedAdds the responsible party’s name and affiliation to the record history and introduces new metadata fields (Last verified, Last known status was, Revision: v3.6.0).SummaryDifference3%

- Check61 days agoChange DetectedThe record history now shows Revision: v3.5.5, updating from the previous v3.5.4. This reflects a new page version rather than a change to study data.SummaryDifference0.1%

- Check82 days agoChange DetectedThe latest revision shown on the page is v3.5.4, replacing the previous v3.5.3 in the history. This indicates a small administrative update to the page revision tracking and footer information.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.